MB 112
Alternative Names: MB-112Latest Information Update: 21 Nov 2023
At a glance
- Originator MediBeacon
- Class Diagnostic agents; Imaging agents
- Mechanism of Action Diagnostic imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Kidney disorders
Most Recent Events
- 04 Oct 2023 Early research in Kidney disorders (Diagnosis) in USA (Parenteral) (MediBeacon pipeline, October 2023)